Insider trade

Calcimedica (CALC)CEO bought ~$3.4K

A. Rachel Leheny, CEO at Calcimedica, bought ~$3.4K of Calcimedica shares.

~$3.4K
Approx. value · 1,000 sh @ $3.40
3,500
Holds after · shares reported
Traded
Jul 21, 2025
Filed
Jul 21, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 30, 2025InsiderCFO purchased ~$1.7K of CALC shares in the open market
  2. Jun 5, 2025InsiderDirector purchased ~$8.7K of CALC shares in the open market
  3. Jun 6, 2025InsiderDirector purchased ~$8.9K of CALC shares in the open market
  4. Jun 11, 2025InsiderDirector purchased ~$9.3K of CALC shares in the open market
  5. Jun 26, 2025Insider · 2 peopleInsiders: 2 purchases (~$9K)
  6. Jul 1, 2025InsiderOfficer purchased ~$1.9K of CALC shares in the open market
  7. Jul 9, 2025InsiderDirector purchased ~$8K of CALC shares in the open market
  8. Jul 14, 2025Insider · 2 peopleInsiders: 2 purchases (~$22K)
  9. Jul 18, 2025Insider · 2 peopleInsiders: 2 purchases (~$19K)
  10. Jul 21, 2025 · this disclosureInsiderCEO purchased ~$3.4K of CALC shares in the open market

What came next

  1. Jul 21, 2025InsiderDirector purchased ~$5.1K of CALC shares in the open market
  2. Jul 22, 2025InsiderDirector purchased ~$5.7K of CALC shares in the open market
  3. Jul 25, 2025InsiderOfficer sold ~$3.6K of CALC shares in the open market
  4. Jul 28, 2025InsiderOfficer purchased ~$4K of CALC shares in the open market
  5. Aug 14, 2025InsiderOfficer purchased ~$4.1K of CALC shares in the open market
  6. Aug 15, 2025Insider · 2 peopleInsiders: 2 purchases (~$27K)
  7. Aug 19, 2025Insider · 2 peopleInsiders: 2 purchases (~$30K)
  8. Aug 20, 2025InsiderDirector purchased ~$5.4K of CALC shares in the open market
  9. Aug 21, 2025InsiderDirector purchased ~$9.8K of CALC shares in the open market
  10. Aug 28, 2025InsiderDirector purchased ~$26K of CALC shares in the open market
  11. Aug 29, 2025InsiderDirector purchased ~$2.2K of CALC shares in the open market
  12. Sep 9, 2025InsiderDirector purchased ~$7.4K of CALC shares in the open market
  13. Sep 12, 2025InsiderDirector purchased ~$16K of CALC shares in the open market
  14. Sep 15, 2025InsiderDirector purchased ~$9.1K of CALC shares in the open market
  15. Sep 18, 2025InsiderDirector purchased ~$7.7K of CALC shares in the open market
  16. Nov 12, 2025Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Calcimedica

OQRO holds no insider, Congress, fund or contract record for Calcimedica dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CALC page.

Other recent filings by A. Rachel Leheny, CHIEF EXECUTIVE OFFICER

The full history of A. Rachel Leheny, CHIEF EXECUTIVE OFFICER is on the profile page.

How this filing works

Other disclosures at Calcimedica

Everything OQRO holds on this company is on its CALC page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data